ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Daxor Corporation

Daxor Corporation (DXR)

8.55
-0.12
( -1.38% )
Updated: 10:57:05

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
8.55
Bid
8.55
Ask
9.19
Volume
2,057
8.55 Day's Range 8.67
7.11 52 Week Range 10.04
Market Cap
Previous Close
8.67
Open
8.62
Last Trade
1000
@
8.55
Last Trade Time
10:57:05
Financial Volume
$ 17,610
VWAP
8.5609
Average Volume (3m)
6,127
Shares Outstanding
4,840,000
Dividend Yield
-
PE Ratio
148.54
Earnings Per Share (EPS)
0.06
Revenue
163k
Net Profit
281k

About Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and compos... Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. Show more

Sector
Surgical,med Instr,apparatus
Industry
Misc Health & Allied Svc,nec
Website
Headquarters
Oak Ridge, New Jersey, USA
Founded
2010
Daxor Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker DXR. The last closing price for Daxor was $8.67. Over the last year, Daxor shares have traded in a share price range of $ 7.11 to $ 10.04.

Daxor currently has 4,840,000 shares outstanding. The market capitalization of Daxor is $41.96 million. Daxor has a price to earnings ratio (PE ratio) of 148.54.

DXR Latest News

DAXOR'S INNOVATIVE BVA-100™ BLOOD VOLUME DIAGNOSTIC FEATURED AT MEDAXIOM CV TRANSFORUM FALL '24

Elite Cardiovascular Leaders Unite: Driving Innovation Through Shared Excellence Oak Ridge, TN, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood...

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael...

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device

Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume...

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024

Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual...

Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management

Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee

The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job Creation Oak Ridge, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global...

Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care

1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume...

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial...

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.22-2.508551881418.779.468.55111248.8845872CS
4-0.66-7.16612377859.219.648.5175819.00113442CS
12-0.77-8.261802575119.329.737.861278.89912174CS
26-1.19-12.21765913769.749.99997.836369.02531959CS
52-0.38-4.255319148948.9310.047.1131908.90061282CS
156-2.42-22.060164083910.9714.557.11400810.01952883CS
260-2.42-22.060164083910.9714.557.11400810.01952883CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
$ 1.12
(195.05%)
191.9M
VERBVerb Technology Company Inc
$ 14.1802
(79.27%)
26.51M
LBPHLongboard Pharmaceuticals Inc
$ 58.845
(51.27%)
28.55M
XPONExpion360 Inc
$ 3.5308
(47.73%)
25.76M
RANIRani Therapeutics Holdings Inc
$ 2.78
(37.62%)
36.57M
MTEMMolecular Templates Inc
$ 0.37
(-74.83%)
4.87M
ZPTAZapata Computing Holdings Inc
$ 0.0813
(-68.85%)
34.41M
SPPLSIMPPLE Ltd
$ 0.33
(-31.25%)
583.87k
TWGTop Wealth Group Holding Ltd
$ 5.00
(-29.97%)
7.93M
VEVVicinity Motor Corporation
$ 0.086
(-26.56%)
4.5M
TVGNTevogen Bio Holdings Inc
$ 1.1198
(194.99%)
191.91M
NVDANVIDIA Corporation
$ 137.62
(2.09%)
122.55M
GRTSGritstone bio Inc
$ 0.0627
(23.18%)
98.98M
JTAIJet AI Inc
$ 0.1118
(10.69%)
87.85M
SQQQProShares UltraPro Short QQQ
$ 7.075
(-1.32%)
68.49M

Discussion

View Full Feed
Controlledoilandgas Controlledoilandgas 25 seconds ago
1 cent spread and low volume price levels to increase price off of buys… are we looking at the same level 2???
GPLS
Triple nickle Triple nickle 57 seconds ago
INVO 1.08
INVO
unvctrader9m unvctrader9m 59 seconds ago
Just dreamers here! Everyone else left the party
Don’t forget the way out when lights are off!!!!
Ok
ASII
HippyTrades HippyTrades 1 minute ago
PSRU
xriera761 xriera761 1 minute ago
So far just at another lower high on the chart.
BTCUSD
Greedy G Greedy G 2 minutes ago
~bought 10/16 $590 calls @.15c
SPY
Ms Labonte Ms Labonte 2 minutes ago
Pop your pill$$ $weet$$ fly time$$$$
WEET
Nrdc92 Nrdc92 2 minutes ago
Exactly, AB. A twenty plus year runway is nothing! Let’s hope our local dealers can sell a “dime bag” in less time.
LWLG
Controlledoilandgas Controlledoilandgas 2 minutes ago
It's a monday and a holiday... look at the broader market... volume down across the board due to the holiday..
GPLS
thesmallguy thesmallguy 2 minutes ago
well.....doesn't make sense to me that the loading in the 6's and 7's last week would now be sold off at 5.
ASII
thesmallguy thesmallguy 2 minutes ago
well.....doesn't make sense to me that the loading in the 6's and 7's last week would now be sold off at 5.
ASII
Hercules1 Hercules1 2 minutes ago
.006 to .01 by Friday.


Load up.
RDAR
Hosai Hosai 2 minutes ago
"Karuna was well-funded and ran well-designed and adequately sized trials."

But why do you describe it as adequetly sized when it was the same size as 2b/3 (which you say was too small) and Anavex had but more people on the actual drug?

They had less excuse to do a low
AVXL
mineanddine mineanddine 2 minutes ago
Shocked to see activity here
SNRY
timberwolf7 timberwolf7 2 minutes ago
1 hour explanation of the event in Nevada
claimed to be a 'possible' 3rd assassination
attempt. I would expect this to turn into a LAWSUIT
against some of the cops involved.

https://rumble.com/v5iml7h-vem-millers-statement-about-the-3rd-assassination-attempt-on-
glenn1919 glenn1919 2 minutes ago
tkno..........................https://stockcharts.com/h-sc/ui?s=tkno&p=W&b=5&g=0&id=p86431144783
TKNO
threewheeler threewheeler 3 minutes ago
yes very happy with my AZRH so far, much more to come, market very slow today as many people took long weekend
AZRH
prototype_101 prototype_101 3 minutes ago
Comprehensive review LWLG known Customer connections

The Customer Funnel slide was updated at the Safe Capital presentation in April 2024 just a few weeks after the OFC 200Gbs World Class demonstrations, this update showed greater than 20 Prospects and greater than 10 Leads, where in
LWLG TWST
Controlledoilandgas Controlledoilandgas 3 minutes ago
NO dilution coming - a share restructuing for the officers is in discussion but nothing formal yet - will report back once we see some progress here which should be over the next week
GPLS
The Night Stalker The Night Stalker 3 minutes ago
nice hit
ZHUD
tdbowieknife tdbowieknife 3 minutes ago
And they STILL have not informed the TA of the one billion share increase in the A/S to 5 Billion shares!!

Lol!

https://investorshub.advfn.com/uimage/uploads/2024/10/4/vmaftGRLT_5_billion.png


..


Buyer Beware
Pump
GRLT
NASDAQ2020 NASDAQ2020 3 minutes ago
Elite will supply the product to Dexcel Pharma (Or Akiva, Israel), the Company's exclusive distributor , for the Israeli market. The product is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy.
ELTP
MetaMonster MetaMonster 3 minutes ago
Yes the only one that is still sucking lemons from the trash can
RNAZ
Acme Investments Acme Investments 3 minutes ago
Easy Money!!
FNMA
Controlledoilandgas Controlledoilandgas 4 minutes ago
HMMMM JUST GOES to show how stupid you are... the bankruptcy is on a person who is an officer of the company... the SEC doesn't require companies to disclose the personal financials of an officer... Liens? what liens? you keep making things up - anybody in america can sue somebody... any Cohen is g
CK GPLS